BACKGROUND: Higher serum phosphorus concentrations within the normal laboratory range have been associated with cardiovascular events and mortality in large prospective cohort studies of individuals with and without kidney disease. Reasons for interindividual variation in steady-state serum phosphorus concentrations are largely unknown. STUDY DESIGN: Cross-sectional study. SETTING & PARTICIPANTS: 15,513 participants in the Third National Health and Nutrition Examination Survey. PREDICTORS: Demographic data, dietary intake measured by means of 24-hour dietary recall and food-frequency questionnaire, and established cardiovascular risk factors. OUTCOME & MEASUREMENTS: Serum phosphorus concentration. RESULTS: Mean serum phosphorus concentrations were significantly greater in women (+0.16 mg/dL versus men; P < 0.001) and people of non-Hispanic black and Hispanic race/ethnicity (+0.06 and +0.07 mg/dL versus non-Hispanic white, respectively; P < 0.001). Dietary intakes of phosphorus and phosphorus-rich foods were associated only weakly with circulating serum phosphorus concentrations, if at all. Higher serum phosphorus levels were associated with lower calculated Framingham coronary heart disease risk scores, which are based on traditional atherosclerosis risk factors. In aggregate, demographic, nutritional, cardiovascular, and kidney function variables explained only 12% of the variation in circulating serum phosphorus concentrations. LIMITATIONS: Results may differ with advanced kidney disease. CONCLUSIONS: Serum phosphorus concentration is weakly related to dietary phosphorus and not related to a diverse array of phosphorus-rich foods in the general population. Factors determining serum phosphorus concentration are largely unknown. Previously observed associations of serum phosphorus concentrations with cardiovascular events are unlikely to be a result of differences in dietary intake or traditional cardiovascular risk factors.
BACKGROUND: Higher serum phosphorus concentrations within the normal laboratory range have been associated with cardiovascular events and mortality in large prospective cohort studies of individuals with and without kidney disease. Reasons for interindividual variation in steady-state serum phosphorus concentrations are largely unknown. STUDY DESIGN: Cross-sectional study. SETTING & PARTICIPANTS: 15,513 participants in the Third National Health and Nutrition Examination Survey. PREDICTORS: Demographic data, dietary intake measured by means of 24-hour dietary recall and food-frequency questionnaire, and established cardiovascular risk factors. OUTCOME & MEASUREMENTS: Serum phosphorus concentration. RESULTS: Mean serum phosphorus concentrations were significantly greater in women (+0.16 mg/dL versus men; P < 0.001) and people of non-Hispanic black and Hispanic race/ethnicity (+0.06 and +0.07 mg/dL versus non-Hispanic white, respectively; P < 0.001). Dietary intakes of phosphorus and phosphorus-rich foods were associated only weakly with circulating serum phosphorus concentrations, if at all. Higher serum phosphorus levels were associated with lower calculated Framingham coronary heart disease risk scores, which are based on traditional atherosclerosis risk factors. In aggregate, demographic, nutritional, cardiovascular, and kidney function variables explained only 12% of the variation in circulating serum phosphorus concentrations. LIMITATIONS: Results may differ with advanced kidney disease. CONCLUSIONS:Serum phosphorus concentration is weakly related to dietary phosphorus and not related to a diverse array of phosphorus-rich foods in the general population. Factors determining serum phosphorus concentration are largely unknown. Previously observed associations of serum phosphorus concentrations with cardiovascular events are unlikely to be a result of differences in dietary intake or traditional cardiovascular risk factors.
Authors: Bryan Kestenbaum; Joshua N Sampson; Kyle D Rudser; Donald J Patterson; Stephen L Seliger; Bessie Young; Donald J Sherrard; Dennis L Andress Journal: J Am Soc Nephrol Date: 2004-12-22 Impact factor: 10.121
Authors: A E Bowe; R Finnegan; S M Jan de Beur; J Cho; M A Levine; R Kumar; S C Schiavi Journal: Biochem Biophys Res Commun Date: 2001-06-22 Impact factor: 3.575
Authors: Vandana Menon; Tom Greene; Arema A Pereira; Xuelei Wang; Gerald J Beck; John W Kusek; Alan J Collins; Andrew S Levey; Mark J Sarnak Journal: Am J Kidney Dis Date: 2005-09 Impact factor: 8.860
Authors: Josef Coresh; Brad C Astor; Geraldine McQuillan; John Kusek; Tom Greene; Frederick Van Lente; Andrew S Levey Journal: Am J Kidney Dis Date: 2002-05 Impact factor: 8.860
Authors: Eric W Young; Justin M Albert; Sudtida Satayathum; David A Goodkin; Ronald L Pisoni; Takashi Akiba; Tadao Akizawa; Kiyoshi Kurokawa; Jürgen Bommer; Luis Piera; Friedrich K Port Journal: Kidney Int Date: 2005-03 Impact factor: 10.612
Authors: Jerry Meng; Claes Ohlsson; Gail A Laughlin; Michel Chonchol; Christina L Wassel; Osten Ljunggren; Magnus K Karlsson; Dan Mellstrom; Eric S Orwoll; Elizabeth Barrett-Connor; Joachim H Ix Journal: Kidney Int Date: 2010-06-09 Impact factor: 10.612
Authors: Nicole E Jensky; Joseph A Hyder; Matthew A Allison; Nathan Wong; Victor Aboyans; Roger S Blumenthal; Pamela Schreiner; J Jeffrey Carr; Christina L Wassel; Joachim H Ix; Michael H Criqui Journal: J Bone Miner Res Date: 2011-11 Impact factor: 6.741
Authors: Ravi Dhingra; Philimon Gona; Emelia J Benjamin; Thomas J Wang; Jayashri Aragam; Ralph B D'Agostino; William B Kannel; Ramachandran S Vasan Journal: Eur J Heart Fail Date: 2010-08 Impact factor: 15.534
Authors: Alvaro Alonso; Jennifer A Nettleton; Joachim H Ix; Ian H de Boer; Aaron R Folsom; Aurelian Bidulescu; Bryan R Kestenbaum; Lloyd E Chambless; David R Jacobs Journal: Hypertension Date: 2010-01-18 Impact factor: 10.190
Authors: Heather L Palomino; Dena E Rifkin; Cheryl Anderson; Michael H Criqui; Mary A Whooley; Joachim H Ix Journal: Clin J Am Soc Nephrol Date: 2013-03-28 Impact factor: 8.237